Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on August 6, 2026

Aug. 6, 2026

MIND CTI Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Inevitable AI Group Raises $6M From Aleph to Launch AI-Native SaaS Companies

Indeterminate GlobeNewswire

Aug. 6, 2026

Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms

Indeterminate GlobeNewswire

Aug. 6, 2026

Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform

Indeterminate GlobeNewswire

Aug. 6, 2026

Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026

Indeterminate GlobeNewswire

Aug. 6, 2026

HI-VIEW IDENTIFIES FIVE HIGH-PRIORITY CHARGEABILITY ANOMALIES AT THE BOREALIS PORPHYRY TARGET IN THE TOODOGGONE

Indeterminate GlobeNewswire

Aug. 6, 2026

Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder

Indeterminate GlobeNewswire

Aug. 6, 2026

RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors

Indeterminate GlobeNewswire

Aug. 6, 2026

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Indeterminate GlobeNewswire

Aug. 6, 2026

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Indeterminate GlobeNewswire

Aug. 6, 2026

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

Indeterminate GlobeNewswire

Aug. 6, 2026

Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Vortex Energy Receives Final Technical Study Results for the Robinsons River Salt Project

Indeterminate GlobeNewswire

Aug. 6, 2026

GoldHaven Awards Contract for Eight-Hole, 1,650-Metre Phase II Drill Program at Copeçal West Target, Brazil

Indeterminate GlobeNewswire

Aug. 6, 2026

Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

Aug. 6, 2026

Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement

Indeterminate GlobeNewswire

Aug. 6, 2026

Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study

Indeterminate GlobeNewswire

Aug. 6, 2026

Nayax Files Application to Establish Nayax America Bank in the United States

Indeterminate GlobeNewswire